FMI analysis suggests that the future growth of the gene repair creams market will no longer be driven by conventional anti-ageing claims or passive sun protection, but by clinically validated DNA repair enzymes, epigenetic modulation, and molecular correction of UV-induced damage. FMI views the gene repair creams market as a sector poised to evolve from cosmetic skincare into preventive dermatological care, where enzyme-based repair, peptide delivery, and gene-targeted technologies will integrate into routine post-procedure protocols and long-term skin health management, making molecular repair a standard component of advanced skincare.